CDT Equity Inc. (CDT)
NASDAQ · Manufacturing · Pharmaceutical preparations
$0.0800−$0.0410 (−33.88%) on the dayAs of the close; data may be delayed.
CDT price, last 12 months
Key stats
- Previous close
- $0.1210
- Open
- $0.0884
- Day range
- $0.0786 – $0.0887
- 52-week range
- $0.0786 – $1,778.00
- Volume
- 26.7M
- Avg volume (20 days)
- 8.1M
- Market cap
- $1.1M
Performance
1W−54.0%
1M−95.8%
3M−98.7%
6M−99.9%
YTD−100.0%
1Y−100.0%
vs S&P 500, 1Y−116.8 pts
Technicals and fundamentals
About CDT Equity Inc.
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $1.1M